UBA5
Basic information
Region (hg38): 3:132654446-132679794
Previous symbols: [ "UBE1DC1" ]
Links
Phenotypes
GenCC
Source:
- undetermined early-onset epileptic encephalopathy (Supportive), mode of inheritance: AD
- developmental and epileptic encephalopathy, 44 (Strong), mode of inheritance: AR
- spinocerebellar ataxia, autosomal recessive 24 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental and epileptic encephalopathy 44; Spinocerebellar ataxia, autosomal recessive 24 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 26872069; 27545674; 27545681 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (8 variants)
- Developmental and epileptic encephalopathy, 44 (6 variants)
- Early infantile epileptic encephalopathy with suppression bursts (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UBA5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 50 | 50 | ||||
missense | 76 | 86 | ||||
nonsense | 5 | |||||
start loss | 1 | |||||
frameshift | 10 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 1 | 4 | 5 | 10 | ||
non coding | 45 | 51 | ||||
Total | 14 | 12 | 81 | 97 | 3 |
Highest pathogenic variant AF is 0.00000658
Variants in UBA5
This is a list of pathogenic ClinVar variants found in the UBA5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-132659702-T-G | Uncertain significance (Nov 11, 2013) | |||
3-132659706-G-A | not specified | Uncertain significance (Feb 11, 2022) | ||
3-132659715-C-A | Developmental and epileptic encephalopathy, 44 | Pathogenic (Apr 18, 2019) | ||
3-132659724-C-T | not specified | Likely benign (Dec 07, 2021) | ||
3-132660504-C-T | Likely benign (Dec 01, 2023) | |||
3-132660529-G-A | UBA5-related disorder | Likely benign (Jan 04, 2023) | ||
3-132660538-A-G | Developmental and epileptic encephalopathy, 44 | Pathogenic (May 04, 2022) | ||
3-132660541-G-A | Uncertain significance (Jul 22, 2021) | |||
3-132660542-C-T | Uncertain significance (Mar 18, 2021) | |||
3-132660543-G-A | Likely benign (Jul 12, 2022) | |||
3-132660547-T-C | Uncertain significance (Jul 05, 2022) | |||
3-132660557-G-A | Likely benign (Dec 13, 2023) | |||
3-132660558-C-T | Likely benign (Oct 03, 2023) | |||
3-132660572-TCC-T | Developmental and epileptic encephalopathy, 44 | Pathogenic (May 04, 2022) | ||
3-132660577-G-A | Uncertain significance (Jan 19, 2021) | |||
3-132660600-G-A | Likely benign (Jun 18, 2023) | |||
3-132660613-C-G | Uncertain significance (Jun 11, 2022) | |||
3-132660621-G-A | Likely benign (Nov 27, 2023) | |||
3-132660626-GC-G | Pathogenic (Apr 28, 2022) | |||
3-132660628-G-T | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
3-132660644-G-A | Uncertain significance (Dec 11, 2020) | |||
3-132660647-G-A | Uncertain significance (Feb 20, 2022) | |||
3-132660652-C-T | Inborn genetic diseases | Uncertain significance (Mar 29, 2023) | ||
3-132660665-T-TGG | Inborn genetic diseases • UBA5-related disorder | Pathogenic (Jun 13, 2019) | ||
3-132660668-G-C | Uncertain significance (Jul 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UBA5 | protein_coding | protein_coding | ENST00000356232 | 12 | 23652 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000252 | 0.997 | 125707 | 0 | 16 | 125723 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.29 | 158 | 211 | 0.750 | 0.00000988 | 2659 |
Missense in Polyphen | 24 | 51.682 | 0.46438 | 630 | ||
Synonymous | 1.52 | 54 | 70.2 | 0.769 | 0.00000331 | 749 |
Loss of Function | 2.58 | 10 | 23.5 | 0.426 | 0.00000126 | 277 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000117 | 0.000117 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000444 | 0.0000440 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.0000656 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E1-like enzyme which activates UFM1 and SUMO2. {ECO:0000269|PubMed:15071506, ECO:0000269|PubMed:18442052, ECO:0000269|PubMed:20368332, ECO:0000269|PubMed:27545674, ECO:0000269|PubMed:27545681}.;
- Disease
- DISEASE: Spinocerebellar ataxia, autosomal recessive, 24 (SCAR24) [MIM:617133]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR24 patients manifest gait instability and speech difficulties with onset in childhood. Clinical features include gait and limb ataxia, dysarthria, nystagmus, cataracts, and cerebellar atrophy on brain imaging. {ECO:0000269|PubMed:26872069}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- protein ubiquitylation;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.0887
Intolerance Scores
- loftool
- 0.418
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.56
Haploinsufficiency Scores
- pHI
- 0.0632
- hipred
- Y
- hipred_score
- 0.629
- ghis
- 0.516
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.735
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Uba5
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- uba5
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- decreased mobility
Gene ontology
- Biological process
- protein modification by small protein conjugation;regulation of intracellular estrogen receptor signaling pathway;response to endoplasmic reticulum stress;neuromuscular process;protein ufmylation;protein K69-linked ufmylation
- Cellular component
- nucleus;cytoplasm;Golgi apparatus;cytosol;intracellular membrane-bounded organelle
- Molecular function
- protein binding;ATP binding;metal ion binding;UFM1 activating enzyme activity